ClinicalTrials.gg

Kymab Limited clinical trials

Acquired by Sanofi, Apr 9, 2021 · source ↗

The registry lists 5 studies whose lead sponsor is Kymab Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 3, 2025.

Before and after it joined Sanofi

First submitted before Kymab Limited became part of Sanofi
4
First submitted after Kymab Limited became part of Sanofi
1
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Kymab Limited’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

All 5 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed480%
  • Stopped early120%

Phase

  • Phase 23
  • Phase 13

Where

  • United Kingdom4
  • Poland3
  • Taiwan2
  • Hungary2
  • Germany2
  • United States2

Over the years

  1. 117
  2. 18
  3. 19
  4. 20
  5. 21
  6. 22
  7. 23
  8. 24
  9. 25
  10. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Kymab Limited5 studies

Something wrong with this grouping? Tell us on the Sanofi page.

Studies

Recruiting first, then most recently updated. Showing 5 of 5. All Sanofi studies →